More information

Russia's COVID-19 vaccine 'makes water': scientists doubt its results

The Russian vaccine does not quite convince the international community.

14 percent of volunteers who have participated in clinical trials after the official registration of the Russian vaccine against coronavirus, Sputnik V, have suffered side effects such as fever or muscle pain, as reported by the Russian Minister of Health, Mikhail Murashko.

«More than 300 people were vaccinated. 14 percent of them have complaints minor weakness, minor muscle aches during the day and sometimes have a fever.

The minister has stressed that these types of complications are foreseeable and “Are described in the instructions”. In addition, he has said that three large manufacturers have joined the work on the Sputnik V vaccine.

“In parallel, the industrial production of a large number of doses of the vaccine, including lyophilic and liquid forms. To date, three large manufacturers work in this area. The work is progressing according to the road map, “he said.

On August 11, the Nikolai Gamaleya Center for Epidemiology and Microbiology officially registered the Russian vaccine Sputnik V, which will be produced with the cooperation of the Russia Direct Investment Fund (RFPI).

According to the developers, the Russian vaccine has demonstrated stable immunogenicity and will protect against the new coronavirus for up to two years. Post-registration trials of the vaccine began in early September, involving some 40,000 volunteers, as reported by the Russian news agency Sputnik.

The director of the RFPI, Kiril Dimitriev, has said the fund received applications from more than 20 countries to purchase 1,000 million doses of this vaccine. Dimitriev has said that Russia has signed agreements to produce it in five countries, in which the available capacities allow to obtain up to 500 million doses a year.